Listar por autoría "d11a0ebf-53e1-40b1-bb74-2387745d05ea"

Mostrando ítems 1-3 de 3

    • openAccess   Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design 

      Miñana, Gema; Cardells, Ingrid; Palau, Patricia; Llàcer, Pau; Facila Rubio, Lorenzo; Almenar, Luis; López‐Lereu, Maria Pilar; Monmeneu, Jose V.; Amiguet, Martina; González, Jessika; Serrano, Alicia; Montagud, Vicente; López‐Vilella, Raquel; Valero, Ernesto; García-Blas, Sergio; Bodí, Vicent; de la Espriella-Juan, Rafael; Sanchis, Juan; Chorro, Francisco J.; Bayés‐Genís, Antoni; Núñez, Julio; Myocardial‐IRON Investigators Wiley (2018)
      Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for ...

    • openAccess   Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction 

      Amiguet, Martina; Palau, Patricia; Domínguez Mafé, Eloy; Seller, Julia; GARCIA-PINILLA, JOSE MANUEL; De la Espriella, Rafael; Miñana, Gema; Valle, Alfonso; Sanchis, Juan; Górriz, José Luis; Bayés‐Genís, Antoni; DAPA-VO2 Investigators, /; Núñez, Julio Nature Research (2023)
      Circulating antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload in heart failure. This study aimed to evaluate the effect of dapagliflozin on short-term CA125 levels in patients with stable heart ...

    • closedAccess   Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction 

      Lorenzo, Miguel; Miñana, Gema; Palau, Patricia; Amiguet, Martina; Seller, Julia; García Pinilla, José Manuel; Villar, Sandra; De la Espriella, Rafael; Núñez, Eduardo; Górriz, José Luis; Valle, Alfonso; Bodí, Vicent; Sanchis, Juan; Bayes-Genis, Antoni; Núñez, Julio; DAPA-VO2 Investigators Elsevier (2023-05)
      Background: We aimed to evaluate the effect of dapagliflozin on short-term changes in hemoglobin in patients with stable heart failure with reduced ejection fraction (HFrEF) and whether these changes mediated the effect ...